Lineage Cell Therapeutics (LCTX) Preferred Dividend Payments (2014 - 2015)
Lineage Cell Therapeutics (LCTX) reported Preferred Dividend Payments of -$830000.0 for Q4 2015, down 1666.04% on a YoY basis from $53000.0 in Q4 2014, and down 328.65% quarter-over-quarter from $363000.0 in Q3 2015.
Lineage Cell Therapeutics (LCTX) Preferred Dividend Payments (2014 - 2015) Analysis & Trends
Lineage Cell Therapeutics has reported Preferred Dividend Payments for 2 years, with the latest figure at -$830000.0 in Q4 2015.
- For the quarter ending Q4 2015, Preferred Dividend Payments fell 1666.04% year-over-year to -$830000.0; the trailing twelve-month figure through Dec 2016 stood at -$830000.0 (down 129.28% YoY), and the FY2015 full-year result was -$415000.0, down 577.01% from the prior year.
- Preferred Dividend Payments for Q4 2015 stood at -$830000.0, down from $363000.0 in the prior quarter.
- The five-year high for Preferred Dividend Payments was $363000.0 in Q3 2015, with the low at -$830000.0 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Lineage Cell Therapeutics | 303.84 Mn | 239.94 Mn | 1.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | -830,000.00 |
| Sep 30, 2015 | 363,000.00 |
| Jun 30, 2015 | 52,000.00 |
| Dec 31, 2014 | 53,000.00 |
| Sep 30, 2014 | 34,000.00 |
| Jun 30, 2014 | 34,000.00 |